With a 27 October deadline looming for a firm bid, RHI Magnesita's advanced talks to buy fellow FTSE 250 constituent Vesuvius have become the dominant story for its shareholders.

RHI Magnesita (LSE: RHIM), the global supplier of refractory products used to line steel furnaces, cement kilns and glass tanks, is approaching a pivotal moment. On 29 September the company confirmed that it was in advanced discussions over a possible cash-and-share offer for Vesuvius, the London-listed specialist in molten-metal flow control and foundry consumables. Under UK takeover rules, RHI Magnesita must either announce a firm intention to make an offer or walk away by 5pm on 27 October, unless the deadline is extended.

The terms on the table

The latest non-binding proposal, submitted on 27 August, would give Vesuvius shareholders 470p in cash plus roughly 0.028 new RHI Magnesita shares for each share they own. Based on RHI Magnesita's closing price on 28 September, that implied a value of about 549p per Vesuvius share, a premium of around 47% to the target's undisturbed price, and valued Vesuvius at roughly £1.37bn. The cash component would be funded through new debt facilities, and a mix-and-match facility would allow Vesuvius investors to vary the balance of cash and shares they receive.

About 7.1 million new RHI Magnesita shares would be issued, leaving Vesuvius shareholders with approximately 13% of the enlarged group. Cevian Capital, Vesuvius's largest shareholder with a stake of about 23%, has given an irrevocable undertaking to back the proposal if the Vesuvius board recommends it. RHI Magnesita's own board and its major shareholders, including MSP Stiftung and funds affiliated with Rhône, also support the approach. The proposal is the latest in a series; Vesuvius rejected an earlier approach pitched at 448p a share in September 2025. For its part, Vesuvius has said it is assessing the terms carefully.

Market reaction on 29 September followed a familiar pattern. Vesuvius shares surged by more than 20%, on course for their biggest one-day gain since 2008, while RHI Magnesita's London-listed stock slipped about 3%, reflecting investor caution over the price, the extra debt and integration risk.

Balance sheet and trading backdrop

The leverage question is central. At the half-year stage, RHI Magnesita reported net debt of €1,528m, equivalent to about 2.9 times earnings, though it guided for that to fall to around €1.4bn, or roughly 2.6 times, by the end of 2026. A largely debt-funded acquisition of this scale would push gearing higher in the near term, putting the spotlight on the cash generation of the combined business.

Underlying trading has been improving. Results published on 31 July showed first-half revenue of €1,595m, broadly flat at constant currency, while adjusted EBITA rose 17% to €165m, lifting the margin to 10.3% from 8.4%. Adjusted earnings per share increased 32% to €1.81, and the board declared an interim dividend of €0.60, paid on 24 September. Management confirmed full-year adjusted EBITA guidance of around €400m, including an expected €35m currency headwind, and trimmed planned capital expenditure to €115m.

The Steel division, its largest, delivered a 33% jump in adjusted EBITA, aided by stronger demand in the US and India, while the Industrial division remained weak, with project delays and glass demand near historic lows. Costs linked to the Middle East conflict added roughly €28m in the period.

What to watch next

The coming days will determine whether the talks result in a recommended offer, a revised proposal or a withdrawal. Investors will be weighing the industrial logic of combining two major names in steel-related consumables against the financing burden and any competition scrutiny.